“Young or old, family planning should be a simple and personal decision made by informed individuals or couples regarding how often and when to have children,” Anne Alan Sizomu, the advocacy officer for Deutsche Stiftung Weltbevoelkerung’s (DSW) Uganda country office, writes in this post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26. “In order to make informed decisions regarding their future, it is important for young people to have access to timely information and contraceptives,” she continues, adding, “Young people need to demand their reproductive health rights — including access to contraceptives and the ability to decide when to have children” (9/17).
Access to Health Services
As more people move into the urban slum areas surrounding Bangladesh’s capital, Dhaka, basic services such as water, sanitation and health care are being stretched to capacity by “[n]ew residents [who] are increasingly pushed out to the city’s fringes,” the Guardian reports. “According to health care workers, hospitals are already unable to meet the growing demand for treatment and services,” the newspaper writes, adding, “Dhaka’s largest hospital is operating at 50 percent staff capacity and trying to accommodate 3,000 patients in a facility with just 800 beds.” In addition, “no health care facilities are provided in the slums, [so] Dhaka’s newest — and poorest — residents are facing a health care black hole,” according to the Guardian. The news service says women and girls “most often fall through the cracks,” and describes one project “that aims to bridge this gap and prevent urbanization creating a free fall in maternal and infant mortality levels” (Kelly, 9/18).
Researchers from South Africa and South Korea are developing a smartphone-based device and application able to “photograph and analyze blood samples in areas far from laboratories to diagnose HIV and even measure the health of [patients’] immune systems,” Agence France-Presse reports. The device, called Smartscope, is a small microscope that clips over a phone’s camera and holds a standard chip with a blood sample, the news service notes, adding the camera then photographs the sample and the application analyzes the photo to produce a CD4 cell count. “The team hopes that trials in clinics may start next year,” according to AFP (8/31).
“More than 4,000 delegates — including government officials, health experts, community leaders, scientists, indigenous populations, youth and people living with HIV — convened from 28-31 August in Sao Paulo, Brazil, for the 6th Latin American and Caribbean Forum on HIV/AIDS and Sexually Transmitted Infections (STIs),” UNAIDS reports in a feature story. “[T]he forum provided an opportunity to take stock of progress, challenges and lessons learned in HIV responses across the region,” according to UNAIDS, which adds, “Participants engaged on a range of issues, from AIDS financing and new HIV prevention technologies to strategies for closing treatment access gaps.” The article expands on several of these issues (8/31).
“Despite pledges from governments across Eastern Europe and Central Asia to fight HIV/AIDS — one of the eight Millennium Development Goals — the region has the world’s fastest-growing HIV epidemic,” Inter Press Service reports in an article examining challenges to stemming the spread of the disease, particularly among injection drug users. “Punitive drug policies, discrimination and problems with access to medicines and important therapy are all driving an epidemic which is unlikely to be contained, world experts say, until governments in countries with the worst problems change key policies and approaches to the disease,” the news service writes. According to experts and activists, a lack of opiate-substitution therapy (OST) and needle-exchange programs, as well as discrimination against and “active persecution” of drug users who try to access therapy programs, contributes to the spread of HIV, IPS notes (Stracansky, 9/3).
“The non-communicable disease [NCD] community always talks about the importance of prevention; many consider it the Holy Grail in the fight against NCDs. Why was it so hard to also accept treatment as part of the solution?” Princess Dina Mired, director general of the King Hussein Cancer Foundation in Amman, Jordan, asks in the Huffington Post “Impact” blog, noting only one target of the 2011 U.N. High-Level Meeting on NCDs “deals with treatment, the target on ‘essential medicines and basic technologies for treatment.'” She continues, “Treatment and prevention are heavily interrelated. The success of one is directly related to the other.” She adds, “A person in the developing world will not buy in to the importance of prevention if there is no treatment option available should that person get the disease.”
“More than half a million people in northern Mali, occupied by Islamist fighters, need aid to cope with rising food prices, collapsed public services and a lack of health care, the International Committee of the Red Cross said on Thursday,” Reuters reports. “Public services practically no longer function, basic health services are not provided and supplying clean drinking water is difficult. Needs are huge,” Yasmine Praz Dessimoz, head of ICRC operations for North and West Africa, said at a news conference in Geneva, according to the news agency. “The ICRC, which deploys 111 aid workers in Mali, is one of few humanitarian organizations to have access to all of northern Mali, where no United Nations aid agencies deploy any staff,” Reuters notes (Nebehay, 9/13).
In this post in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, published in partnership with Women Deliver as part of a series on youth perspectives to recognize World Contraception Day, observed annually on September 26, youth activist Cecilia Garcia Ruiz writes, “For six years we’ve worked to shine a spotlight on these key issues, but some people still disregard the importance of providing universal access to quality contraceptive services and information to prevent unplanned pregnancies, especially among young people.” She discusses barriers to accessing contraceptive methods and information, and continues, “These problems not only undermine our well-being, but also hinder our possibilities to develop our full potential. Therefore, young people’s access to contraceptive information and services becomes a human rights issue” (9/13).
Pending Cases Against India's Patent Laws Threaten Public Health, Misinterpret International IP Agreements, Report Says
“Pending cases against India’s patent laws threaten public health and misinterpret international intellectual property (IP) agreements,” researchers from Queen Mary, University of London argue in a special report published online in the Lancet on Monday, PharmaTimes reports (Taylor, 9/11). “The report highlights legal challenges by two pharmaceutical companies, Bayer and Novartis, to key provisions of India’s Patents Act,” a university press release notes, adding, “Bayer’s appeal was heard last week, and the Indian Supreme Court is due to hear Novartis’ appeal on 11 September.”
Amanda Glassman, director of global health policy and a senior fellow at the Center for Global Development (CGD), and Kate McQueston, a program coordinator at CGD, write in the center’s “Global Health Policy” blog that a reduction in AIDS funding to Ethiopia from PEPFAR and the Global Fund to Fight AIDS, Tuberculosis and Malaria “might be warranted due to epidemiological trends and improved efficiency, or might cripple progress as health programs dependent on external donors are cut back,” but “with the current poor status of basic information on beneficiaries and costs, it’s difficult to judge whether these cuts are good or bad.” They outline the history of AIDS funding in Ethiopia, posit what future funding might encompass, and say additional information is needed from PEPFAR, the Global Fund, and the Ethiopian government in order to know the true impacts of reduced funding (9/11).